Impinj (PI) Shares Skyrocket, What You Need To Know

Stock Story

What Happened?

Shares of RFID manufacturer Impinj jumped 10.1% in the afternoon session after well-known tech investor Dan Niles named the company a top stock to own for 2026, believing it had reached a major turning point.

Niles highlighted that Impinj, a leader in RFID technology, was at an inflection point as its chip prices dropped to a penny apiece. He noted this development allowed for expansion from the apparel sector into the much larger food and grocery market, with adopters like Walmart. The bullish outlook was supported by news suggesting new applications for RFID technology. Specifically, a recommendation was made for the South Korean military to adopt an RFID system for handling firearms to prevent accidents, indicating a potentially expanding market for the company's products.

What Is The Market Telling Us

Impinj’s shares are extremely volatile and have had 39 moves greater than 5% over the last year. But moves this big are rare even for Impinj and indicate this news significantly impacted the market’s perception of the business.

The previous big move we wrote about was 1 day ago when the stock dropped 6.3% on the news that rising geopolitical tensions between the US and Europe over control of Greenland sparked a broad, risk-off mood in asset markets.

The sell-off was fueled by President Trump's push for the U.S. to acquire Greenland, reviving fears of trade confrontations and new tariffs against European allies. The tech-heavy Nasdaq index saw significant declines, with the "Magnificent Seven" technology stocks, Nvidia, Apple, Alphabet, Amazon, Meta, Microsoft, and Tesla, all sliding to start the week. This widespread downturn among major tech players weighed heavily on the overall market as investors reacted to the escalating political rhetoric.

Impinj is down 5% since the beginning of the year, and at $170.74 per share, it is trading 29.4% below its 52-week high of $241.91 from October 2025. Investors who bought $1,000 worth of Impinj’s shares 5 years ago would now be looking at an investment worth $2,839.

Risk Warnings and Disclaimers

You understand and acknowledge that there is a high degree of risk involved in trading. Following any strategies or investment methods may lead to potential losses. The content on the site is provided by our contributors and analysts for information purposes only. You are solely responsible for determining whether any trading assets, securities, strategy, or any other product is suitable for investing based on your own investment objectives and financial situation.

Add to Favorites

Himax, Broadcom, KLA Corporation, Impinj, and Qualcomm Stocks Trade Down, What You Need To Know

Stock Story

What Happened?

A number of stocks fell in the afternoon session after rising geopolitical tensions between the US and Europe over control of Greenland sparked a broad, risk-off mood in asset markets.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

Analog Semiconductors company Himax fell 4.7%. Is now the time to buy Himax? Access our full analysis report here, it’s free.
Processors and Graphics Chips company Broadcom fell 4.9%. Is now the time to buy Broadcom? Access our full analysis report here, it’s free.
Semiconductor Manufacturing company KLA Corporation fell 4.3%. Is now the time to buy KLA Corporation? Access our full analysis report here, it’s free.
Analog Semiconductors company Impinj fell 6.3%. Is now the time to buy Impinj? Access our full analysis report here, it’s free.
Processors and Graphics Chips company Qualcomm fell 3.5%. Is now the time to buy Qualcomm? Access our full analysis report here, it’s free.

Zooming In On Impinj (PI)

Impinj’s shares are extremely volatile and have had 39 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The previous big move we wrote about was 14 days ago when the stock gained 7.3% on the news that a broader market rally drove investor optimism in artificial intelligence and big tech stocks.

The S&P 500, Dow Jones, and Nasdaq all pushed higher, approaching record levels set late last year. Much of the positive momentum was linked to the technology sector, with a particular focus on companies advancing artificial intelligence, a key theme at the annual CES trade show in Las Vegas. This continued a powerful trend from 2025, when AI-related developments were a primary catalyst for the market's bull run. The upbeat sentiment was further supported by hopes for easier monetary policy from the Federal Reserve following a weaker-than-expected US Services PMI reading.

Impinj is down 15% since the beginning of the year, and at $152.83 per share, it is trading 36.8% below its 52-week high of $241.91 from October 2025. Investors who bought $1,000 worth of Impinj’s shares 5 years ago would now be looking at an investment worth $2,609.

Risk Warnings and Disclaimers

Add to Favorites

These under-the-radar stocks combine fast growth with big upside potential

MarketWatch

By Philip van Doorn

The companies are projected to grow sales rapidly through 2027, and many of the stocks are expected to show double-digit increases this year

Dozens of small-cap U.S. companies are expected to increase their revenue at an annual pace of more than 15% over the next two years.

A screen of small-cap stocks sheds light on companies expected to grow their businesses very rapidly. This bodes well for investors looking for multiyear growth plays. But for many of these companies, analysts expect large increases in stock prices this year.

Earlier this week, Matt Bartolini, the global head of research strategists at State Street Investment Management, made a solid case for investors to increase their exposure to small-cap stocks immediately. These stocks are trading at very low relative valuations to the S&P 500 SPX, and many smaller companies are primed for a bump in profits from declining borrowing costs and from federal income-tax breaks.

In that article we listed several ways for investors to use low-cost index funds to track small-cap stocks, such as the State Street SPDR Portfolio S&P 600 Small Cap ETF SPSM or the iShares Russell 2000 ETF IWM, along with several others.

Some investors will want to dig into individual stocks. For these we have conducted a new stock screen focusing on projected growth rates for revenue.

We began the screen with the S&P Small Cap 600 Index SML. This index is more selective in that S&P Dow Jones Indices' criteria for a company to be added to the index includes four consecutive quarters of positive net income.

Here is how we narrowed down from the initial group of 600 companies:

Stocks covered by at least five analysts polled by LSEG. This brought the list down to 414 companies.
Majority buy or equivalent ratings among the analysts: 204 companies.
Revenue and earnings-per-share estimates available through calendar 2027. The estimates are adjusted for companies whose fiscal reporting periods don't match the calendar. This narrowed the list to 196 companies.
Positive EPS estimates for 2025, 2026 and 2027: 177 companies.

Then we cut the list to 25 companies for which consensus revenue estimates project compound annual growth rates of at least 15% from 2025 through 2027.

Here is an explanation of how we set that target revenue growth rate:

It turns out that based on LSEG's "smart estimates," which remove outliers among analysts' estimates and estimates that haven't been updated or affirmed recently, the S&P Small Cap 600 Index is projected to increase revenue per share at a 4.1% CAGR from 2025 through 2027. The index estimates are weighted by the companies' market capitalization.

For the S&P MidCap 400 Index MID, the projected two-year revenue CAGR is 5.6%, while the projected two-year sales CAGR for the large-cap S&P 500 is 7.4%. So we rounded that up to 7.5% and then doubled it to 15% for our minimum revenue CAGR projection for the small-cap group.

Here is the entire list of 25 companies that passed the screen, sorted by projected revenue CAGR from 2025 through 2027:

   Company                                    Two-year estimated sales CAGR through 2027  Two-year estimated EPS CAGR through 2027  Jan. 14 price  Consensus price target  Implied 12-month upside potential 
   SM Energy Co.                                                                   52.9%                                     -4.3%         $18.57                  $32.25                                74% 
   TG Therapeutics Inc.                                                            40.0%                                     -8.7%         $29.54                  $44.86                                52% 
   Krystal Biotech Inc.                                                            38.0%                                     21.0%        $291.79                 $271.09                                -7% 
   SiTime Corp.                                                                    34.5%                                     46.3%        $349.20                 $352.79                                 1% 
   Beacon Financial Corp.                                                          32.5%                                     40.7%         $26.79                  $31.33                                17% 
   Corcept Therapeutics Inc.                                                       29.6%                                     81.9%         $37.04                  $91.00                               146% 
   StepStone Group Inc.                                                            24.3%                                     22.2%         $73.50                  $75.14                                 2% 
   Impinj Inc.                                                                     23.1%                                     37.5%        $181.36                 $241.11                                33% 
   Millrose Properties Inc.                                                        22.5%                                     13.8%         $30.54                  $38.08                                25% 
   Vital Farms Inc.                                                                22.2%                                     22.3%         $29.55                  $49.45                                67% 
   Agilysys Inc.                                                                   20.9%                                     31.0%        $112.71                 $139.72                                24% 
   Supernus Pharmaceuticals Inc.                                                   19.7%                                     31.2%         $51.80                  $61.33                                18% 
   FB Financial Corp.                                                              19.3%                                     14.4%         $59.14                  $65.17                                10% 
   TransMedics Group Inc.                                                          19.1%                                     16.9%        $141.96                 $146.00                                 3% 
   DigitalOcean Holdings Inc.                                                      19.1%                                      9.3%         $52.70                  $54.33                                 3% 
   CareTrust REIT Inc.                                                             18.9%                                      8.2%         $37.25                  $40.70                                 9% 
   Vericel Corp.                                                                   18.9%                                     86.9%         $37.33                  $55.00                                47% 
   Palomar Holdings Inc.                                                           18.4%                                     12.9%        $130.31                 $164.75                                26% 
   Astrana Health Inc.                                                             18.3%                                     94.8%         $25.68                  $36.89                                44% 
   Dime Community Bancshares Inc.                                                  18.1%                                     30.4%         $30.11                  $34.50                                15% 
   Harmonic Inc.                                                                   17.8%                                     58.3%          $9.95                  $11.79                                18% 
   Cactus Inc.                                                                     17.1%                                     12.6%         $52.00                  $51.00                                -2% 
   Essential Properties Realty Trust Inc.                                          16.6%                                      5.7%         $30.45                  $35.76                                17% 
   Enova International Inc.                                                        15.7%                                     18.0%        $159.90                 $184.50                                15% 
   Mirion Technologies Inc.                                                        15.2%                                     20.7%         $26.25                  $30.50                                16% 
                                                                                                                                                                                             Source: FactSet

Among the 25 companies, consensus price targets indicate double-digit (or better) upside potential for 18 of them over the next 12 months. However, that might be considered a relatively short period for committed investors looking at rapidly growing companies.

Click on the tickers for more about each company.

Read: Tomi Kilgore's guide to the wealth of information available for free on the MarketWatch quote page

Don't miss: This ETF from a 106-year-old firm has crushed rivals while avoiding 'Magnificent Seven' stocks

-Philip van Doorn

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

Risk Warnings and Disclaimers

Add to Favorites

Impinj Stock Is Falling. Why Solid Guidance Isn't Boosting the Chip Maker. — Barrons.com

Dow Jones Newswires

Impinj

-3.59%

By George Glover

Impinj stock was tumbling on Wednesday after the radio-frequency identification chip maker issued solid enough earnings and revenue guidance. Investors were pricing in perfection for the fourth quarter.

Shares, which trade under the ticker PI, dropped 5.3% to $189 ahead of the opening bell. Futures tracking the S&P 500 were 0.2% lower as the market awaited bank results, a slew of economic data, and a potential Supreme Court ruling on tariffs.

Impinj late Tuesday gave investors an update about its fourth-quarter earnings, due out on Feb. 5. The company expects to report adjusted earnings before interest, taxes, depreciation, and amortization above the midpoint of its prior guidance of $15.4 to $16.9 million, on revenue near the high end of its prior guidance of $90 million to $93 million.

Analysts were expecting adjusted Ebitda of $15.8 million on sales of $91.8 million, according to a FactSet poll.

Wall Street was probably hoping that Impinj would hike its quarterly guidance, which looks a little modest compared with previous quarters. Susquehanna Financial Group analyst Christopher Rolland said in October that the fourth-quarter guidance was "perhaps a disappointment for bulls, as it appears much of the third-quarter strength may have come at the expense of the fourth quarter." He rates the stock at a Buy, with a $255 price target that implies upside of 28% upside.

Impinj describes itself as an "Internet of Things" pioneer, referring to its chips' role in tagging everyday products for computer systems. Shares jumped 20% last year, beating the S&P 500's 16% gain.

Write to George Glover at george.glover@dowjones.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

Risk Warnings and Disclaimers

Add to Favorites

Impinj (PI): Buy, Sell, or Hold Post Q3 Earnings?

Stock Story

Impinj

-3.59%

Impinj has been on fire lately. In the past six months alone, the company’s stock price has rocketed 72.2%, reaching $194.03 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.

Is now still a good time to buy PI? Or are investors being too optimistic? Find out in our full research report, it’s free.

Why Does Impinj Spark Debate?

Founded by Caltech professor Carver Mead and one of his students Chris Diorio, Impinj is a maker of radio-frequency identification (RFID) hardware and software.

Two Things to Like:

1. Skyrocketing Revenue Shows Strong Momentum

A company’s long-term sales performance can indicate its overall quality. Any business can put up a good quarter or two, but many enduring ones grow for years. Thankfully, Impinj’s 20.2% annualized revenue growth over the last five years was exceptional. Its growth beat the average semiconductor company and shows its offerings resonate with customers. Semiconductors are a cyclical industry, and long-term investors should be prepared for periods of high growth followed by periods of revenue contractions.

2. Increasing Free Cash Flow Margin Juices Financials

If you’ve followed StockStory for a while, you know we emphasize free cash flow. Why, you ask? We believe that in the end, cash is king, and you can’t use accounting profits to pay the bills.

As you can see below, Impinj’s margin expanded by 15.8 percentage points over the last five years. This is encouraging because it gives the company more optionality. Impinj’s free cash flow margin for the trailing 12 months was 11.3%.

Impinj Trailing 12-Month Free Cash Flow Margin

One Reason to be Careful:

Previous Growth Initiatives Have Lost Money

Growth gives us insight into a company’s long-term potential, but how capital-efficient was that growth? Enter ROIC, a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

Although Impinj has shown solid business quality lately, it struggled to grow profitably in the past. Its five-year average ROIC was negative 22.4%, meaning management lost money while trying to expand the business.

Impinj Trailing 12-Month Return On Invested Capital

Final Judgment

Risk Warnings and Disclaimers

Add to Favorites

IPG Photonics, Magnachip, Kulicke and Soffa, Impinj, and Semtech Shares Are Soaring, What You Need To Know

Stock Story

IPG Photonics

+0.98%

Kulicke & Soffa Industries

MagnaChip Semiconductor

-0.35%

What Happened?

A number of stocks jumped in the afternoon session after a broader market rally drove investor optimism in artificial intelligence and big tech stocks.

The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks.

Among others, the following stocks were impacted:

Semiconductor Manufacturing company IPG Photonics jumped 3%. Is now the time to buy IPG Photonics? Access our full analysis report here, it’s free for active Edge members.
Analog Semiconductors company Magnachip jumped 3.2%. Is now the time to buy Magnachip? Access our full analysis report here, it’s free for active Edge members.
Semiconductor Manufacturing company Kulicke and Soffa jumped 4.1%. Is now the time to buy Kulicke and Soffa? Access our full analysis report here, it’s free for active Edge members.
Analog Semiconductors company Impinj jumped 7.3%. Is now the time to buy Impinj? Access our full analysis report here, it’s free for active Edge members.
Semiconductor Manufacturing company Semtech jumped 4%. Is now the time to buy Semtech? Access our full analysis report here, it’s free for active Edge members.

Zooming In On Impinj (PI)

Impinj’s shares are extremely volatile and have had 36 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.

The biggest move we wrote about over the last year was 11 months ago when the stock dropped 25.9% on the news that the company reported disappointing fourth quarter results, with revenue slightly missing Wall Street estimates and next-quarter revenue, EBITDA, and earnings guidance falling significantly short. EBITDA also missed, suggesting profits are under pressure, while earnings came in roughly in line. Management is anticipating near-term headwinds, suggesting the company is not out of the woods yet. Overall, this quarter could have been better.

Impinj is up 7.4% since the beginning of the year, but at $193.10 per share, it is still trading 20.2% below its 52-week high of $241.91 from October 2025. Investors who bought $1,000 worth of Impinj’s shares 5 years ago would now be looking at an investment worth $4,281.

Risk Warnings and Disclaimers

Add to Favorites

13D Filings — Barrons.com

Dow Jones Newswires

These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Dec. 11 through Dec. 17, 2025. Source: VerityData

Activist Filings

Cannae Holdings (CNNE) Carronade Capital Management raised its stake in the diversified holding company to 3,262,648 shares. Carronade and its affiliates did so through the purchase of 81,633 Cannae Holdings shares from Oct. 23 through Nov. 11 at per share prices of $15.76 to $18.44. On Dec. 12, Carronade issued a news release, expressing its satisfaction over the election of independent Carronade-backed directors Mona Aboelnaga and Cherie Schaible to the board at the 2025 annual meeting. Carronade also commented on the rejection of Cannae's "Say on Pay" proposal, saying that the "continued unjust enrichment of its directors and management must cease." Following the latest purchases, Carronade owns 6.8% of Cannae's outstanding stock. Shares of Cannae have lost roughly 18.7% of their value in 2025.

Increases in Holdings

NextDecade (NEXT) Hanwha Aerospace raised its stake in the liquid natural-gas producer to 25,620,222 shares. Hanwha did so through the purchase of 7,082,525 NextDecade shares from Nov. 11 through Dec. 11 at per share prices of $5.59 to $6.36. After the latest purchases, Hanwha owns a 9.7% stake in NextDecade's outstanding stock. Shares of NextDecade have lost about 37.5% of their value in 2025.

Decreases in Holdings

V2X (VVX) American Industrial Partners lowered its stake in the government services company to 5,017,286 shares. American Industrial Partners did so through the sale of 1,200,000 V2X shares on Dec. 12 at a price of $55.05 per share. Following the latest sales, American Industrial Partners owns a 16.1% stake in V2X's outstanding stock. Shares of V2X have gained roughly 14.9% in value in 2025.

Impinj (PI) Sylebra Capital lowered its stake in the wireless chip maker to 1,132,152 shares. Sylebra Capital did so through the sale of 372,225 Impinj shares from Dec. 4 through Dec. 15 at per share prices of $146.62 to $161.04, after selling another 324,883 Impinj shares from Nov. 3 to Dec. 3 at $155.09 to $201.99. Following the latest sales, Sylebra Capital continues to own 3.8% of Impinj's outstanding stock, placing Sylebra below the 5% threshold that would require it to report further sales. Shares of Impinj have gained roughly 13.5% in value since the beginning of this year.

Alphatec Holdings (ATEC) Squadron Capital reduced its stake in the medical technology company to 13,215,781 shares. Squadron Capital did so through the sale of 1,000,000 Alphatec Holdings shares from Nov. 12 through Dec. 16 at per share prices ranging from $19.66 to $21.20. Following the latest sales, Squadron Capital continues to own 8.9% of Alphatec's outstanding stock. Shares of Alphatec have gained approximately 116% in value since the beginning of this year.

Email: editors@barrons.com

This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.

Risk Warnings and Disclaimers

Add to Favorites